6493-06-7
Chemical Structure
(±)-Lisofylline
Synonym(s): (±)-Lisophylline
- CAS No.: 6493-06-7
- Formula:C13H20N4O3
- Molecular Weight:280.33
IUPAC Name: 1-(5-hydroxyhexyl)-3,7-dimethyl-3,7-dihydro-1H-purine-2,6-dione
InChIKey: NSMXQKNUPPXBRG-UHFFFAOYSA-N
SMILES: O=C(N1CCCCC(O)C)N(C)C2=C(N(C)C=N2)C1=O
Biological Activity: (±)-Lisofylline ((±)-Lisophylline) is the racemate of Lisofylline. Lisofylline inhibits the generation of phosphatidic acid and free fatty acids. Lisofylline also blocks the release of pro-inflammatory cytokines in oxidative tissue injury, in response to cancer chemotherapy and in experimental sepsis. Lisofylline can be used for Type 1 diabetes research[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
(±)-Lisofylline | 98.57% | (±)-Lisofylline ((±)-Lisophylline) is the racemate of Lisofylline. Lisofylline inhibits the generation of phosphatidic acid and free fatty acids. Lisofylline also blocks the release of pro-inflammatory cytokines in oxidative tissue injury, in response to cancer chemotherapy and in experimental sepsis. Lisofylline can be used for Type 1 diabetes research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
(±)-Lisofylline (Standard) | ≥98% | (±)-Lisofylline (Standard) is the analytical standard of (±)-Lisofylline. This product is intended for research and analytical applications. (±)-Lisofylline ((±)-Lisophylline) is the racemate of Lisofylline. Lisofylline inhibits the generation of phosphatidic acid and free fatty acids. Lisofylline also blocks the release of pro-inflammatory cytokines in oxidative tissue injury, in response to cancer chemotherapy and in experimental sepsis. Lisofylline can be used for Type 1 diabetes research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
(±)-Lisofylline-d6 | (±)-Lisofylline-d6 is the deuterium labeled (±)-Lisofylline. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
(±)-Lisofylline-d3 | (±)-Lisofylline-d3 is the deuterium labeled (±)-Lisofylline. (±)-Lisofylline ((±)-Lisophylline) is the racemate of Lisofylline. Lisofylline inhibits the generation of phosphatidic acid and free fatty acids. Lisofylline also blocks the release of pro-inflammatory cytokines in oxidative tissue injury, in response to cancer chemotherapy and in experimental sepsis. Lisofylline can be used for Type 1 diabetes research. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
(±)-Lisofylline-d4 | (±)-Lisofylline-d4 ((±)-Lisophylline-d4) is deuterium labeled (±)-Lisofylline. (±)-Lisofylline ((±)-Lisophylline) is the racemate of Lisofylline. Lisofylline inhibits the generation of phosphatidic acid and free fatty acids. Lisofylline also blocks the release of pro-inflammatory cytokines in oxidative tissue injury, in response to cancer chemotherapy and in experimental sepsis. Lisofylline can be used for Type 1 diabetes research. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
Similarity Score 1.00
HY-109854(S)-Lisofylline -
Similarity Score 1.00
HY-109854A(R)-Lisofylline -
Similarity Score 0.87
HY-W273690Pentifylline -
Similarity Score 0.86
HY-B0715Pentoxifylline -
Similarity Score 0.85
HY-Z8258Pentoxifylline impurity 1 -
Similarity Score 0.83
HY-171128PTX-M -
Similarity Score 0.83
HY-N97571-(3-Carboxypropyl)-3,7-dimethylxanthine -
Similarity Score 0.83
HY-121985Protheobromine -
Similarity Score 0.78
HY-U00142A-802715 -
Explore the MedChemAI to find more analogs
